Federal regulations have evolved over time to improve consumer safety. As mentioned, the FDA makes attempts to balance pharmaceutical drug innovation with public access to affordable medicines. The processes involved have implications on physicians and pharmacists prescribing medications. Physicians and pharmacists need to consider the bioequivalence of generic drugs when prescribing and educating patients. Furthermore, health professionals involved in researching novel drugs should be cognizant of the processes and federal regulations surrounding drug development. A better understanding of these regulations by physicians and pharmacists alike will enhance the difficult process of drug development. [Level 5]